Usamos cookies para entender cómo los inversores usan El Fondo y mejorar sus herramientas, datos y mercados para ti. Puedes aceptar o rechazar; las cookies esenciales siempre están activas. Política de Privacidad

Cotiza cerca de 65% por debajo de su sector: más barata que sus pares según sus ganancias.
Shandong Weigao Group Medical Polymer Company Limited, founded in 2000 and situated in Weihai, People's Republic of China, specializes in the research, development, production, and distribution of disposable medical devices across mainland China. The company structures its extensive operations into several core divisions, including Medical Device Products, Orthopaedic Products, Interventional Products, Pharma Packaging Products, Blood Management Products, and other specialized segments. Its comprehensive product range covers a vast array of essential healthcare items. This includes devices for both vascular and non-vascular access, such as infusion sets, syringes, and specialized puncture needles, alongside various clinical collection kits. Shandong Weigao also provides solutions for wound care, offering sutures, healing dressings, cleaning products, and support devices for non-vascular catheters. In the realm of blood management, it supplies equipment for collection, storage, separation, and sterilization. The company is also a manufacturer of prefilled and pre-flush syringes, as well as instruments for blood collection and glucose monitoring. Its portfolio further extends to anesthesia consumables (general, local, and auxiliary), intensive care unit (ICU) equipment, and tools for both open and minimally invasive surgical procedures. Beyond disposables, the firm is a key producer of orthopedic devices, instruments for tumor and blood vessel interventions, and advanced medical components such as implantation materials and artificial organs. It also ventures into industrial manufacturing, producing medical-grade PVC granules, various plastic packaging materials, carton boxes, automated industrial equipment and parts, molds, and hemodialysis machines, encompassing Type I, Type II, and Type III medical devices. In addition to its manufacturing activities, Shandong Weigao offers a range of supporting services. These include finance leasing and factoring, wholesale distribution of Type I, surgical, and other disposable medical products. The company also provides asset management, enterprise consulting, management advisory, and comprehensive logistics and storage solutions, while actively exporting its products to international markets. Operating under recognized brands like Jierui, Wego Ortho, Yahua, Bangde, and Hai Xing, the company serves a diverse clientele that includes hospitals, blood banks, various other medical facilities, and a broad network of distributors.
Cargando el historial completo de precios…
Haz tus propios númerosEl rendimiento pasado no es un pronóstico.
Guarda 1066.HK y te avisamos cuando algo se mueva.
Recibe novedades
Resumen semanal claro y directo.
Aprende los fundamentos detrás de este activo.
Una acción es una fracción de propiedad de una empresa real. Compras una y eres dueño de un pedazo, casi siempre pequeño, de cada escritorio, fábrica, contrato y marca que la empresa maneja. El precio se mueve porque el mercado revisa todo el tiempo cuánto vale el pastel completo.
El ratio precio-utilidades es cuánto pagan los inversionistas por un dólar de utilidades de una empresa. Es un múltiplo, nunca un valor absoluto. Siempre se compara contra algo: un sector, una región, la propia historia de la empresa.
El rendimiento de dividendos es el ingreso anual que paga una acción o un ETF, expresado como porcentaje de lo que pagaste por él. Es la parte visible del retorno total: el efectivo que cae en tu cuenta cada trimestre y la palanca que el inversionista minorista de verdad siente.
La capitalización de mercado es acciones por precio. Una fórmula corta que produce números enormemente desiguales: una sola tecnológica estadounidense puede valer más que todas las empresas de una bolsa latinoamericana juntas.